References
- Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med. 2010;11(12):928–935.
- Weitzman LB, Tinker WP, Kronzon I, et al. The incidence and natural history of pericardial effusion after cardiac surgery – an echocardiographic study. Circulation. 1984;69(3):506–511.
- Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart. 2001;86(2):235–240.
- Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J. 2004;25(7):587–610.
- Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007;115(21):2739–2744.
- Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000;109(2):95–101.
- Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–1197.
- Najib MQ, Ganji JL, Raizada A, et al. Epicardial fat can mimic pericardial effusion on transoesophageal echocardiogram. Eur J Echocardiogr. 2011;12(10):804.
- Spodick DH. Acute cardiac tamponade. N Engl J Med. 2003;349(7):684–690.
- Shabetai R. Pericardial effusion: haemodynamic spectrum. Heart. 2004;90(3):255–256.
- Roy CL, Minor MA, Brookhart MA, et al. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007;297(16):1810–1818.
- Ristic AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35(34):2279–2284.
- Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011;97(22):1882–1892.
- Beck C. Two cardiac compression triads. J Am Med Assoc. 1935;104:714–716.
- Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol. 1995;75(5):378–382.
- Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43(6):1042–1046.
- Imazio M. Evaluation and management of pericarditis. Expert Rev Cardiovasc Ther. 2011;9(9):1221–1233.
- Kussmaul A. Uber schwielige Mediastino-Perikarditis und den paradoxen Puls. Berl Klin Wochenschr. 1873;10:433–435.
- Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27(3):308–317.
- Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916–928.
- Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med. 2009;10(3):217–230.
- Sliwa K, Mocumbi AO. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol. 2010;99(2):65–74.
- Corey GR, Campbell PT, van Trigt P, et al. Etiology of large pericardial effusions. Am J Med. 1993;95(2):209–213.
- Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine. 2003;82(6):385–391.
- Reuter H, Burgess LJ, Doubell AF. Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect. 2005;133(3):393–399.
- Ma W, Liu J, Zeng Y, et al. Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients. Herz. 2012;37(2):183–187.
- Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112(23):3608–3616.
- Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007;93(10):1176–1183.
- Syed FF, Ntsekhe M, Mayosi BM, Tailoring diagnosis and management of pericardial disease to the epidemiological setting. Mayo Clinic Proc. 2010;852:866. author reply 866
- Meurin P, Weber H, Renaud N, et al. Evolution of the postoperative pericardial effusion after day 15: the problem of the late tamponade. Chest. 2004;125(6):2182–2187.
- Hogue CW Jr., Creswell LL, Gutterman DD, et al. Epidemiology, mechanisms, and risks: American College of Chest Physicians Guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128(2Suppl):9s–16s.
- Wessman DE, Stafford CM. The postcardiac injury syndrome: case report and review of the literature. South Med J. 2006;99(3):309–314.
- Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27(23):2846–2857.
- Mitchell LB. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol. 2011;27(1):91–97.
- Imazio M. The post-pericardiotomy syndrome. Curr Opin Pulm Med. 2012;18(4):366–374.
- Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013;168(2):648–652.
- Kataoka H. Pericardial and pleural effusions in decompensated chronic heart failure. Am Heart J. 2000;139(5):918–923.
- Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–2964.
- Yared K, Baggish AL, Picard MH, et al. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging. 2010;3(6):650–660.
- Verhaert D, Gabriel RS, Johnston D, et al. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging. 2010;3(3):333–343.
- Rajiah P, Kanne JP. Computed tomography of the pericardium and pericardial disease. J Cardiovasc Comput Tomogr. 2010;4(1):3–18.
- Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson. 2009;11:14.
- Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol. 2008;127(1):17–26.
- Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med. 2010;11(11):785–794.
- Syed FF, Mayosi BM. A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis. 2007;50(3):218–236.
- Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160(4):662–670.
- Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012–2016.
- Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522–1528.
- Imazio M, Brucato A, Belli R, et al. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 – systematic review and meta-analysis. J Cardiovasc Med. 2014;15(12):840–846.
- Alabed S, Cabello JB, Irving GJ, et al. Colchicine for pericarditis. Cochrane Database Syst Rev. 2014;8:Cd010652.
- Imazio M, Brucato A, Trinchero R, et al. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30(5):532–539.
- Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667–671.
- Maggiolini S, Gentile G, Farina A, et al. Safety, efficacy, and complications of pericardiocentesis by real-time echo-monitored procedure. Am J Cardiol. 2016;117(8):1369–1374.
- Ristic AD, Wagner HJ, Maksimovic R, et al. Epicardial halo phenomenon: a guide for pericardiocentesis? Heart Fail Rev. 2013;18(3):307–316.
- Molkara D, Tejman-Yarden S, El-Said H, et al. Pericardiocentesis of noncircumferential effusions using nonstandard catheter entry sites guided by echocardiography and fluoroscopy. Congenit Heart Dis. 2011;6(5):461–465.
- Sagrista Sauleda J, Almenar Bonet L, Angel Ferrer J, et al. The clinical practice guidelines of the Sociedad Espanola de Cardiologia on pericardial pathology. Revista Espanola de Cardiologia. 2000;53(3):394–412.
- Finkelstein Y, Shemesh J, Mahlab K, et al. Colchicine for the prevention of postpericardiotomy syndrome. Herz. 2002;27(8):791–794.
- Imazio M, Trinchero R, Brucato A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31(22):2749–2754.
- Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. Jama. 2014;312(10):1016–1023.
- Izadi Amoli A, Bozorgi A, HajHossein Talasaz A, et al. Efficacy of colchicine versus placebo for the treatment of pericardial effusion after open-heart surgery: a randomized, placebo-controlled trial. Am Heart J. 2015;170(6):1195–1201.
- Meurin P, Lelay-Kubas S, Pierre B, et al. Colchicine for postoperative pericardial effusion: a multicentre, double-blind, randomised controlled trial. Heart. 2015;101(21):1711–1716.
- Zhao J, Cheng Z, Quan X, et al. Does posterior pericardial window technique prevent pericardial tamponade after cardiac surgery? J Int Med Res. 2014;42(2):416–426.
- Kaya M, Satilmisoglu MH, Bugra AK, et al. Impact of the total pericardial closure using bilateral trap door incision and pericardial cavity intervention on outcomes following coronary artery bypass grafting: a randomized, controlled, parallel-group prospective study. Interact Cardiovasc Thorac Surg. 2015;21(6):727–733.
- Frohlich GM, Keller P, Schmid F, et al. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur Heart J. 2013;34(19):1414–1423.
- Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124(11):1270–1275.
- Adachi S, Hirashiki A, Nakano Y, et al. Prognostic factors in pulmonary arterial hypertension with Dana Point group 1. Life Sci. 2014;118(2):404–409.
- Benza RL, Miller DP, Foreman AJ, et al. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis. J Heart Lung Transplant. 2015;34(3):356–361.
- Jobs A, Eitel C, Poss J, et al. Effect of pericardial effusion complicating ST-elevation myocardial infarction as predictor of extensive myocardial damage and prognosis. Am J Cardiol. 2015;116(7):1010–1016.
- Mitiku TY, Heidenreich PA. A small pericardial effusion is a marker of increased mortality. Am Heart J. 2011;161(1):152–157.
- Yuda S, Hayashi T, Yasui K, et al. Pericardial effusion and multiple organ involvement are independent predictors of mortality in patients with systemic light chain amyloidosis. Intern Med. 2015;54(15):1833–1840.
- Sagrista-Sauleda J, Angel J, Permanyer-Miralda G, et al. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999;341(27):2054–2059.
- Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113(12):1622–1632.